Key Market Indicators
Norwegian pipeline transport volume is projected to reach 10.2 billion tonne-kilometers by 2026, a 3.3% increase from the 2021 figure of 8.1 billion. Since 1993, Norway's demand has grown 16.3% each year. France overtook Norway in 2021, with the US, China and Kazakhstan in second, third and fourth place, respectively. Meanwhile, the Norwegian pipeline length is forecast to shrink by 2% annually to 1,030 kilometers in 2026, from 1,140 kilometers in 2021. Since 1997, the country's supply has declined by 2.3% annually. Austria overtook Norway in 2021, with Italy, Romania and Poland coming in second, third and fourth place, respectively.
Norway Pipeline Transportation Market Data and Forecasts
How much will Norway Pipeline Transportation Market grow to 2026?
Improve your Knowledge with the latest Indicators and Trends
The global lubricants market has been exhibiting steady growth, driven by industrialization and mechanization in developing economies. Availability of a plethora of products, each with unique functional characteristics catering to diverse industry demands, contributes to this trend. The demanding industrial environment necessitates the use of high performance lubricants to ensure...Read more
The global market for transport of goods through pipelines is witnessing steady growth, driven by an increased demand for crude oil, natural gas, and refined products. Key industry players are investing in the development and expansion of pipeline infrastructure to meet this escalating demand. In addition, advancements in technology have...Read more
The Ophthalmology pipeline is witnessing a rapid evolution fueled by technological advancements and an improved understanding of ocular diseases. Critical diseases, such as Uveitis and Blepharitis, are gaining attention with numerous prospective therapies under development. Uveitis treatments, marked by anti-inflammatory, immunosuppressive drugs and biologicals, are shifting to a more personalized...Read more
In the highly competitive healthcare sector, cancer treatment continues to be a focal point. Both large pharmaceutical firms and burgeoning biotech companies are vigorously researching and developing innovative therapies to combat various types of cancer. The substantial influx of resources into these projects during the H1 2020 timeframe is noteworthy,...Read more
In the first half of 2020, the therapeutic pipeline in the healthcare industry saw strong activity. A significant number of clinical trial pipeline projects were made across varying stages of development - preclinical, clinical, and registration phases. These trials cover a broad range of therapeutic areas, with biotechnology companies working...Read more